Catalyst Wire Dossier Catalyst Wire Dossier

MLN518

· Millennium Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MLN518, covering 2008-02-11 to 2008-02-11. Get the full timeline:

Most recent: Clinical Trial Update: MLN518 in Combination With Standard Induction Chemo. for Treatment of Patients With Newly Diagnosed Acute Myelogenous Leukemia [Phase 1]

See pricing